Introduction
============

Coronavirus is a large family of viruses that cause mild to moderate upper respiratory infections. However, some types of coronavirus can also cause more serious illnesses, such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and coronavirus disease 2019 (COVID-19) \[[@B1]\]. Up to now, seven coronaviruses (HCoVs) have been identified, namely HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, SARS-CoV, MERS-CoV, and COVID-19.

COVID-19 is a member of the coronaviridae family, which by the early of May 2020 has infected more than 3.5 million people and caused almost 250.000 deaths worldwide. The spread of COVID-19 is expanding globally within less than 3 months and causing many losses in various sectors \[[@B1]\]. Severe acute respiratory syndrome (SARS) is an acute respiratory disorder caused by a coronavirus (SARS-CoV). During the global outbreak in 2002/2003, this catastrophic disease resulted in 8,400 cases and 900 deaths according to a report by the World Health Organization \[[@B2]\]. MERS-CoV is an emerging virus that is involved in cases of acute respiratory infections in the Arabian Peninsula, Tunisia, Morocco, France, Italy, Germany, and England. The novel coronavirus, which has been contagious in Saudi Arabia since March 2012, has never before been found in the world and has characteristics that are different from the SARS coronavirus that infected 32 countries in the world in 2003 \[[@B3]\].

All types of coronaviruses cause clinical symptoms that can include fever, coughing, acute respiratory distress, pneumonia, fatigue, headaches, dyspnea, lymphopenia, and infrequently cause gastrointestinal symptoms such as diarrhea. Severe COVID-19 infection can be characterized by turbidity in both lung subpleural areas, acute respiratory distress syndrome, and acute cardiac injury. In critical patients occur both local and systemic immune responses, which lead to intense inflammation \[[@B1][@B4]\].

Vaccination is still the most effective preventive for virus infection. One of the latest vaccine technology developments are peptide-based vaccines or epitope vaccines. Epitope based vaccine is synthesized based on in silico analyzes through an immunoinformatics approach. In silico studies reduce costs and time needed in developing vaccines and construct vaccines with higher efficacy and safety than conventional vaccines \[[@B5][@B6][@B7]\].

Looking at the global pandemic COVID-19, MERS, and SARS caused by coronavirus, it is considered necessary to develop an effective vaccine against all types of coronavirus. Alignment of nine strains of the coronavirus has now been carried out and a highly conserved region of the S2 spike protein has been found. Highly conserved regions can be potential vaccine candidates because they can recognize various strains of the coronavirus.

Spike protein is a surface protein in coronavirus that plays a role in binding with receptors and facilitating membrane fusion. The spike S1 protein plays a role in binding virions to the cell membrane through its interaction with the receptors so that it initiates the infection process. S2 protein facilitates fusion between virions and cell membranes \[[@B8][@B9]\].

Materials and Methods
=====================

Data collection
---------------

Spike protein sequences from nine coronavirus strains were collected from protein data bank (<https://www.uniprot.org/>) ([Table 1](#T1){ref-type="table"}).

Alignment and epitopes prediction
---------------------------------

Nine spike protein sequences were aligned using COBALT (constraint-based multiple alignment tools) which is available at <https://www.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi>. Highly conservatives\' sequences were chosen and analyzed its B cells epitope using several tools (Emini Surface Accessibility Prediction, Chou and Fasman Beta-turn Prediction, Parker hydrophilicity prediction, Kolaskar Tongaonkar Antigenicity for linear epitopes) and DiscoTope for continuous epitopes. While the T cell epitopes were predicted using NetCTL, Immune Epitope Database (IEDB)-major histocompatibility complex (MHC) I, IEDB-MHC II, and MotifScan tools.

Results
=======

Highly conserved region from coronavirus spike protein
------------------------------------------------------

Spike protein sequences from nine strains of coronavirus which infected human were collected. Alignment result showed a highly conserved region in amino acid number 945--1100 from severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) spike protein ([Fig. 1](#F1){ref-type="fig"}). This region was used to predict the T and B cells epitopes.

T cells and B epitopes
----------------------

Several tools to predict T cells epitopes identified epitopes that presented by MHC class I and II ([Table 2](#T2){ref-type="table"}). While, the B cells linear epitopes prediction was presented in [Table 3](#T3){ref-type="table"}, the continuous B cells epitopes is demonstrated in [Fig. 2](#F2){ref-type="fig"}. In summary, all of the epitopes identified in highly conserved region is revealed in [Fig. 3](#F3){ref-type="fig"}.

Discussion
==========

Vaccination is one of the most effective approaches to prevent viral infections. However, the development of vaccines requires a long time and high costs since it is required for the screening of large arrays of potential epitope candidates. Using the *in-silico* predictions method, it can dramatically reduce the cost for vaccine development. The immune system recognizes antigens through the mechanism of humoral and cellular immune systems, each of which is mediated by B cells and T cells. Both types of immune cells recognize the antigen not as a whole but only in a portion of the pathogenic components called antigens. The introduction of B cell antigens and T cells requires a different process \[[@B10]\].

We predict epitopes from spike glycoprotein (S protein) since this protein has been studied as the most antigenic part of the virus \[[@B11]\]. Prior to epitope prediction, sequencing of S protein sequences of nine strains of the coronavirus was carried out. From this alignment, it is obtained that the highly conserved region is from amino acid residue number 945--1100.

From the highly conserved region, epitope prediction is carried out; both B cell epitope and T cell epitope. Epitope prediction is performed in the highly conserved area with the intention that the vaccine can be used for a variety of coronavirus strains, including it is expected that if a new type of virus strain develops in the future, the area this is conserved and vaccination remains effective. Our findings provide a sequence from highly conserved region of S2 protein which can help guide new experimental efforts to develop coronavirus vaccine candidate.

B cell epitope prediction is performed to predict both linear and continuous epitopes. From the prediction of linear epitopes in the highly conserved region it was found that the area contained several potential epitopes. Prediction of continuous epitopes has similar results with the presence of epitopes that is recognized by B cells in the spike protein. T cell epitopes prediction in highly conserved region also has similar results. The conclusion of these predictions is the presence of epitopes in the highly conserved region so that they can be developed as vaccine candidates.

The results of this study can be a reference for the next stage of coronavirus vaccine development. A delivery strategy that can be useful in the development of the coronavirus vaccine is by the mucosal pathway using live bacteria vector as a career. Live bacteria become an important career because they can induce the mucosal immune system in addition to the systemic immune system \[[@B12]\], the mucosal immune system is very important to defense against viral infections that attack the respiratory tract.
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![Highly conserve region form coronavirus spike protein, amino acid number 945--1,100 was used to predict epitopes.](cevr-9-169-g001){#F1}

![Continuous B cells epitope predicted from highly conserved region and its residues (180 residues).](cevr-9-169-g002){#F2}

![Selected highly conserved region for epitopes prediction is presented in yellow, T cell epitopes showed in underlined font, and B cell linear epitopes showed in red, numbers indicated the amino acid.](cevr-9-169-g003){#F3}

###### Coronavirus ID number

![](cevr-9-169-i001)

  No.   ID       Organism name
  ----- -------- ----------------------------------------------------------------------------------
  1\.   Q6Q1S2   Human coronavirus NL63 (HCoV-NL63)
  2\.   P36334   Human coronavirus OC43 (HCoV-OC43)
  3\.   P0DTC2   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
  4\.   P59594   Human SARS coronavirus (severe acute respiratory syndrome coronavirus, SARS-CoV)
  5\.   P15423   Human coronavirus 229E (HCoV-229E)
  6\.   K9N5Q8   Middle East respiratory syndrome-related coronavirus
  7\.   Q0ZME7   Human coronavirus HKU1 (isolate N5) (HCoV-HKU1)
  8\.   Q5MQD0   Human coronavirus HKU1 (isolate N1) (HCoV-HKU1)
  9\.   Q14EB0   Human coronavirus HKU1 (isolate N2) (HCoV-HKU1)

###### T cells epitopes prediction result

![](cevr-9-169-i002)

  No.   Start   Stop   Peptide           Methods   MHC class   Prediction based on   Tool           
  ----- ------- ------ ----------------- --------- ----------- --------------------- ------ --- --- -------------
  1     1038    1046   RVDFCGKGY         ANN       I           √                     √      √   √   NetCTL
  2     1016    1024   AEIRASANL         ANN       I           √                                    IEDB-MHC I
  3     1015    1029   AAEIRASANLAATKM   ANN       II          √                                    IEDB-MHC II
  4     1038    1046   RVDFCGKGY         SM        I and II                          √              MotifScan
  5     1041    1050   FCGKGYHLM         QSAR      I and II    √                                    MHCPred

MHC, major histocompatibility complex; A, quantitative binding affinity; S, supertypes; T, TAP binding; P, proteasomal cleavage; ANN, artificial neural network; IEDB, Immune Epitope Database; SM, sequence motif; QSAR, quantitative structure-activity relationship model.

###### Linear B cells epitope predicted from highly conserved region

![](cevr-9-169-i003)

  No.    Start   Stop           Peptide                                                                          Tool                                     Method
  ------ ------- -------------- -------------------------------------------------------------------------------- ---------------------------------------- ---------------------------------
  1\.    987     996            EAEVQIDRL                                                                        Bepiprep                                 Machine learning-decision trees
  1034   1045    LGQSKRVDFCGK                                                                                                                             
  2\.    1067    1075           VPAQEKNFT                                                                        Emini Surface Accessibility Prediction   Propensity scale
  1085   1090    GKAHFP                                                                                                                                   
  3\.    1053    1059           PQSAPHG                                                                          Chou and Fasman Beta-turn Prediction     Propensity scale
  4\.    960     966            NTLVKQL                                                                          Kolaskar Tongaonkar Antigenicity         Propensity scale
  972    978     ISSVLND                                                                                                                                  
  1004   1011    LQTYVTQQ                                                                                                                                 
  1079   1084    PAICHD                                                                                                                                   
  5\.    1071    1147           QEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITT DNTFVSGNCDVVIGIVNNTVYDPLQPELDS   Ellipro                                  
